|
Smith & nephew is submitting this report pursuant to the provisions of 21 c.F.R.Part 803.This report may be based upon information which smith & nephew has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, smith & nephew, or its employees, that the report constitutes an admission that the device, smith & nephew or its employees caused or contributed to the potential event described in this report.(b)(4).
|
|
Given the nature of the alleged incident, the device, could not be returned for evaluation.However, the photographs were reviewed, and revealed that the box and stickers are labeled as left, and the implanted tibial base is right.The clinical/medical investigation concluded that, based on the information provided, the root cause of the reported event was multifactorial as the right sided product was in a package labeled left but was also not verified prior to implantation.According to the report, the procedure was completed with the same device with a non- significant delay, although, the status of the patient is unknown.Therefore, the patient impact beyond the reported non-significant surgical delay and modified surgical procedure could not be determined and notes if a future revision is planned, the information was not provided.A review of the production order did not reveal a manufacturing abnormality that could have caused or contributed to the reported incident.A review of complaint history for the part number over the past 12 months and for the batch number based on historical data of the device did not reveal similar events for the listed device.A review of the instructions for use documents for knee systems revealed in the preoperative section that the surgeon should read the package, implant labels, and the corresponding product and surgical technique information to become familiar with the implants, instruments, and surgical technique before using smith & nephew products.An adequate inventory should be available at the time of surgery.A review of the risk management file revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to this product and event.According to the label specification, the label should specify the correct side orientation of the device which should be "left".Besides, as per inspection drawing, it includes the verification of part configuration per print and left-hand part.According to a review made by the quality engineering team, it was determined that the mispack was a single-piece swap.No further action will be taken at this time as the sister part involved with the swap was contained.If another complaint is received for this product, a new investigation will be opened and additional actions may be taken at that time.At this time, we do have reason to suspect that the product failed to meet specifications at the time of manufacture.The root cause of this event was determined to be a product swap at the manufacturing process and failure to verify the implant configuration prior to implantation.Based on this investigation, the need for corrective action is not indicated.Should additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
|